Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Gains from Investment Securities (2022 - 2025)

Gossamer Bio's Gains from Investment Securities history spans 4 years, with the latest figure at $5000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 100.08% year-over-year to $5000.0; the TTM value through Dec 2025 reached $5000.0, up 100.62%, while the annual FY2025 figure was $5000.0, 100.62% up from the prior year.
  • Gains from Investment Securities reached $5000.0 in Q4 2025 per GOSS's latest filing, up from -$6.1 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $5.6 million in Q3 2024 to a low of -$6.1 million in Q4 2024.
  • Average Gains from Investment Securities over 4 years is $247555.6, with a median of $5000.0 recorded in 2025.
  • The largest YoY upside for Gains from Investment Securities was 866.12% in 2024 against a maximum downside of 933.61% in 2024.
  • A 4-year view of Gains from Investment Securities shows it stood at $3.0 million in 2022, then plummeted by 76.03% to $726000.0 in 2023, then plummeted by 933.61% to -$6.1 million in 2024, then soared by 100.08% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Gains from Investment Securities are $5000.0 (Q4 2025), -$6.1 million (Q4 2024), and $5.6 million (Q3 2024).